L Crinò

High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free survival in resected non-small-cell lung cancer patients.

L. Crinò, M. Tonato, V. Ludovini, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up.

S Senan, C. Dooms, A. Marchetti, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

E. Felip, L. Crinò, J. V. van Meerbeeck, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Evaluation of serum HER2 extracellular domain in early breast cancer patients: correlation with clinicopathological parameters and survival.

S Gori, L. Crinò, I. Floriani, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II study.

G. Scagliotti, F. de Marinis, L. Crinò, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Increased levels of circulating DNA in patients with systemic autoimmune diseases: A possible marker of disease activity in Sjögren’s syndrome

L. Crinò, V. Ludovini, R. Gerli, 2011, Lupus.